Oriflame received advice from Gibson Dunn about its extensive recapitalization transaction from an ad hoc group of noteholders. A strategic balance sheet deleveraging of almost €520 million, a substantial infusion of new capital, and large maturity extensions were all part of the completely agreed deal.